Clinical Trial Update: Intranasal Insulin for Autism Spectrum Disorder in Children and Young Adults Aged 4 to 21 Years

View source ↗

Summary

A clinical trial investigates intranasal insulin as a treatment for Autism Spectrum Disorder in children and young adults aged 4 to 21 and is currently enrollin…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Autism Spectrum Disorder

Drugs mentioned

• Intranasal insulin (insulin)

Snippet

Sponsor: Healing Hope International | Conditions: Autism Spectrum Disorder, Autism Spectrum Disorder (ASD) | Status: ENROLLING_BY_INVITATION